Colorectal Neoplasms Clinical Trials in Vienna
2 recruitingVienna, Austria
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled383 locationsNCT05253651
Recruiting
Establishment of a Tumor Bank for Tissue Samples
Breast NeoplasmsOvarian NeoplasmsLung Neoplasms+3 more
Medical University of Vienna10,000 enrolled3 locationsNCT01789229